Mn Services Vermogensbeheer B.V. Buys 7,500 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Mn Services Vermogensbeheer B.V. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 365,300 shares of the healthcare conglomerate’s stock after acquiring an additional 7,500 shares during the quarter. UnitedHealth Group accounts for 1.2% of Mn Services Vermogensbeheer B.V.’s portfolio, making the stock its 11th biggest holding. Mn Services Vermogensbeheer B.V.’s holdings in UnitedHealth Group were worth $184,791,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. K.J. Harrison & Partners Inc boosted its position in UnitedHealth Group by 1.4% during the 4th quarter. K.J. Harrison & Partners Inc now owns 1,855 shares of the healthcare conglomerate’s stock valued at $936,000 after acquiring an additional 25 shares in the last quarter. Apriem Advisors acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $384,000. Nwam LLC increased its holdings in shares of UnitedHealth Group by 4.5% in the fourth quarter. Nwam LLC now owns 4,386 shares of the healthcare conglomerate’s stock valued at $2,219,000 after purchasing an additional 188 shares during the period. GenTrust LLC lifted its stake in UnitedHealth Group by 2.5% during the 4th quarter. GenTrust LLC now owns 2,375 shares of the healthcare conglomerate’s stock valued at $1,201,000 after acquiring an additional 57 shares during the period. Finally, Heritage Investors Management Corp boosted its holdings in UnitedHealth Group by 1.9% in the fourth quarter. Heritage Investors Management Corp now owns 68,313 shares of the healthcare conglomerate’s stock valued at $34,557,000 after purchasing an additional 1,262 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on UNH. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Barclays decreased their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Down 1.4 %

UnitedHealth Group stock opened at $463.69 on Thursday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a market cap of $426.73 billion, a PE ratio of 29.92, a P/E/G ratio of 1.37 and a beta of 0.61. The stock has a 50-day moving average price of $517.50 and a 200 day moving average price of $558.41. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the business earned $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.